Engineered TCR T-cell therapy targeting mass spectrometry-identified natural epitope in PDAC is a research paper published in Cancer Letters (2023). On theSindex it has a DataRank of 0. It has been cited 13 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Sidney Kimmel Comprehensive Cancer Center
Grant: P30 CA006973
National Institutes of Health
Grant: R01 CA169702
National Institutes of Health
Grant: R01 CA197296
Johns Hopkins University
Japan Society for the Promotion of Science
FWCI
1.50
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Overcome the challenge for intratumoral injection of STING agonist for pancreatic cancer by systemic administration
Additional file 1 of Overcome the challenge for intratumoral injection of STING agonist for pancreatic cancer by systemic administration